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Interventional Cardiology
CoStar Drug-Eluting Stent Fails in Large Clinical Trial
There is concern that the polymer used to attach the drug to drug-eluting stents(DES), which is nondegradable, may trigger late stent thrombosis. The CoStar
stent is a novel DES platform designed to elute paclitaxel, from a bioresorbable
polymer. The COSTAR (Cobalt Chromium Stent With Antiproliferative for Reste-
nosis) II study was a noninferiority trial which randomized patients to either a CoStar
or a Taxus stent with clinical and angiographic follow-up. Major adverse cardiac events
at 8 months were 11% for CoStar versus 6.9% for Taxus. These results demonstrate
that the CoStar DES is inferior to the Taxus DES. See page 1543. See figure.
Lipids and Vascular Disease
Plant Sterols May Decrease Cholesterol But Increase Cardiac Risk
Plant sterol esters (PSEs), which can be found in vegetable oils, fruits, and nuts, arewidely used as a food additive to inhibit the absorption of cholesterol from the
small intestine. Weingärtner and colleagues studied the effectiveness of PSEs at reduc-
ing cardiovascular risk in mice models. Supplementing mice chow with PSEs was
found to impair endothelium dependent vasodilation and to increase infarct size in an
occlusion-reperfusion model. Further studies showed that these PSEs can be incorpo-
rated into human atherosclerotic lesions. These findings suggest that while PSEs may
lower serum cholesterol levels, they may raise rather than lower cardiovascular risk.
See page 1553.
Heart Failure
Presence of Retinopathy Predicts Risk of CHF in Diabetics
Retinopathy is one of the hallmarks of microvascular disease. Cheung and col-leagues graded retinal microphotographs from diabetics enrolled in the ARIC
(Atherosclerosis Risk in Communities) study to determine the association between
diabetic retinopathy and incident congestive heart failure (CHF). Those with retinop-
athy were 2.7 times more likely to be diagnosed with CHF during the 9 years of
follow-up; this association held after adjusting for several risk factors. The authors
hypothesize that diabetic retinopathy may represent systemic microcirculatory disease
that places an increased impedance burden on the heart. See page 1573.
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Cardiac Imaging
Cardiovascular Magnetic Resonance
Can Identify Areas of Salvaged Myocardium
Early reperfusion can limit the extent of myocardial necrosis, but the extent of thissalvage is hard to quantify. The region of irreversible damage can be accurately
identified with late enhancement (LE) on cardiac magnetic resonance imaging.
Friedrich and colleagues hypothesized that T2 imaging, which is sensitive to water-
bound protons, could detect areas of tissue edema that would result from temporary
ischemia. Ninety-two post-myocardial infarction patients were imaged a median of 3
days after the event. Areas of high T2 intensity surrounded areas of LE and exceeded the
infarct size by an average of 16%. This method appears valuable for quantifying the
amount of myocardium salvaged by early reperfusion.See page 1581. See figure.
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Peripheral Vascular Disease
PAD is a Potent Risk Marker for Cardiovascular Death
While peripheral arterial disease (PAD) is known to be a risk factor for cardiovas-cular events, the magnitude of this risk is poorly understood. Welten and
colleagues followed nearly 3,000 subjects who underwent surgery for PAD, and
compared them to a propensity-matched cohort of patients with coronary artery
disease (CAD). The PAD patients were 2.4 times more likely to die and 46% of these
deaths were secondary to cerebrocardiovascular events. Yet PAD patients received less
cardiac medications. Long-term prognosis of vascular surgery patients is significantly
worse than patients with CAD; this difference may be due to the fact that these patients
receive less cardiac medications. See page 1588. See figure.
